Would rather be SCUBA diving
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Will take a trip to St Pete This week. Was in New Orleans for Mardi Gras last week.
$ADGS $8.00+ Weeeeeeeeeeeeeeeee
$ADGS - Wow what a great move!
ICBU Company Tweeting Filings coming:
#Icbu working on getting current with Secretary of State and all financials and disclosures for $icbu. Looking forward to great things to come.
— IMD Companies Inc. (@imd_inc) February 28, 2020
Volume says someone knows something. ICBU
MYFT +80% go baby Go!
MYFT Great IBox DD Nice news on Control Change.
Any legit DD on this ADGS other than Huge price bump?
ICBU thanks for the tip off Goodolboy!
ICBU I found it. PVC pipes India Man thats a good one.
https://www.otcmarkets.com/stock/ICBU/news/iMD-Companies-Inc-Subsidiary-LCG-Plastic-Receives-Purchase-Order-and-Completes-Contract-to-Supply-178-Billion-Dollars-of?id=211359
ICBU Goodolboy how far back was that last Multi BN PR?
ICBU Scam or no SCAM thoughts?
Everyone tries to link Xu now.
Ibox updated for STSN
STSN see they have updated and maintained OTC to remove shell status and to stay current and Pink Status. will monitor.
STSN any DD links anyone can share?
OTC shows Pink Current
Any news on STSN? Heard Stem Cells and CBD but not sure.
SPOM Academic Partners Prestigious Universities! Yale McGill Toronto Bethune
In the past five years, Gerpang has established strategic partnerships with various universities in biomedicine in Toronto, Montreal, Boston, New York and Connecticut, and has established a wide range of government resource management and business contacts. The relationships have resulted in multi-level investments by Gerpang in more than 20 projects.
GREAT NEWS $142-$200MN company coming in!
https://www.otcmarkets.com/stock/SPOM/news/CORRECTION--SPO-Global-and-Gerpang-Healthcare-Group-Complete-Merger-Agreement?id=254301
TODAYs PR SPOM
Link: https://www.otcmarkets.com/stock/SPOM/news/CORRECTION--SPO-Global-and-Gerpang-Healthcare-Group-Complete-Merger-Agreement?id=254301
CORRECTION — SPO Global and Gerpang Healthcare Group Complete Merger Agreement
Press Release | 02/19/2020
TAMPA, Fla., Feb. 19, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today by SPO Global, Inc. (OTC Markets: SPOM), please note that in the third sentence of the second paragraph $580,000 million should read $580,000. The corrected release follows:
SPO Global, Inc. (OTC Markets: SPOM) (the “Company”), has completed its previously announced merger with Gerpang Healthcare Group (“Gerpang”) of Shandong, China.
The acquisition closed on February 19, 2020, and, as previously discussed, all officers and directors of SPO Global have been replaced by the management of Gerpang. Mr. Lu Fengyou has been appointed CEO and Mr. Liangjian Peng has been appointed Secretary. Mr. Fengyou Lu, the CEO and founder of Gerpang Healthcare Group, has 24 years of business experience in the pharmaceutical market in the Greater China region and has successfully run four foreign-funded enterprises and large private enterprises. He is also a Chairman of Pioneer Zhongrun Biotechnology Co., Ltd. and CEO of Canada SOTA Biomedical Investment Co., Ltd. Mr. Lu is a strategic partner of Pioneer Zhongrun (Beijing) Stroke International Specialist Hospital. Previously, Mr. Lu was a Professor of the School of Pharmaceutical Science of Shandong University.
As part of the merger, a total of $1.23 million of existing debt was cancelled. Of this amount, $650,000 of debt previously assumed by the Company from Wine Stream was cancelled and 19.4 million shares were returned from Wine Stream shareholders in exchange for the return of IP, licensing and revenue participation rights. Remaining Company debt holders agreed to cancel $580,000 in debt and convert $1,100,000 of debt, bringing the total shares outstanding in the Company at the time of merger to 42,000,000. Gerpang Shareholders were issued 160,000,000 shares of the Company’s common stock bringing the total shares outstanding to 202,000,000 with no convertible debt post-merger.
The Company’s CIO, Saeb Jannoun, stated: “We were successful in working with our debt holders to complete this merger with Gerpang Healthcare. The merger marks a very exciting and important point in the Company’s history.”
About SPO Global Inc. (OTC Markets: SPOM). The Company is a diversified holding company whose strategy is to acquire interests in a range of profitable ventures. Gerpang Healthcare Group (www.gerpanghealthcare.com), is located in Jinan Pharma Valley Industrial Park, High-tech District. It is an innovative technology-based private and high-tech enterprise. The main business scope of the Gerpang includes bio-pharmaceutical R&D, development and sales of medical information software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, medicine and agents, as well as sales of medical equipment supplies. In addition to having a staff of over 220 people, Gerpang has more than 10 international and national patents and its annual turnover is approximately RMB 1 billion.
In the past five years, Gerpang has established strategic partnerships with various universities in biomedicine in Toronto, Montreal, Boston, New York and Connecticut, and has established a wide range of government resource management and business contacts. The relationships have resulted in multi-level investments by Gerpang in more than 20 projects.
Company Disclaimers: As a "penny stock" Company, within the meaning of federal and state securities law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.
Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
SPOM 10 ITNL PATENTS $1Bn Yuan
About SPO Global Inc. (OTC Markets: SPOM). The Company is a diversified holding company whose strategy is to acquire interests in a range of profitable ventures. Gerpang Healthcare Group (www.gerpanghealthcare.com), is located in Jinan Pharma Valley Industrial Park, High-tech District. It is an innovative technology-based private and high-tech enterprise. The main business scope of the Gerpang includes bio-pharmaceutical R&D, development and sales of medical information software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, medicine and agents, as well as sales of medical equipment supplies. In addition to having a staff of over 220 people, Gerpang has more than 10 international and national patents and its annual turnover is approximately RMB 1 billion.(RMB = Yuan)
SPOM NO DEBT POST MERGER! OS now at 202MN for $1.5Bn Company in Revs. Target $4.00 price or higher.
As part of the merger, a total of $1.23 million of existing debt was cancelled. Of this amount, $650,000 of debt previously assumed by the Company from Wine Stream was cancelled and 19.4 million shares were returned from Wine Stream shareholders in exchange for the return of IP, licensing and revenue participation rights. Remaining Company debt holders agreed to cancel $580,000 in debt and convert $1,100,000 of debt, bringing the total shares outstanding in the Company at the time of merger to 42,000,000. Gerpang Shareholders were issued 160,000,000 shares of the Company’s common stock bringing the total shares outstanding to 202,000,000 with no convertible debt post-merger.
Experienced CEO onboard! Old SPO officers and directors exec team has left and new team installed.
The acquisition closed on February 19, 2020, and, as previously discussed, all officers and directors of SPO Global have been replaced by the management of Gerpang. Mr. Lu Fengyou has been appointed CEO and Mr. Liangjian Peng has been appointed Secretary. Mr. Fengyou Lu, the CEO and founder of Gerpang Healthcare Group, has 24 years of business experience in the pharmaceutical market in the Greater China region and has successfully run four foreign-funded enterprises and large private enterprises. He is also a Chairman of Pioneer Zhongrun Biotechnology Co., Ltd. and CEO of Canada SOTA Biomedical Investment Co., Ltd. Mr. Lu is a strategic partner of Pioneer Zhongrun (Beijing) Stroke International Specialist Hospital. Previously, Mr. Lu was a Professor of the School of Pharmaceutical Science of Shandong University.
SPOM Rocket mode! Don't believe any Talk about Splits thats and old trick to steal your shares they all want more cause they sold under .25 today.
SPOM GUNNA BE DCGD 2.0 FOR 2020! SHMP WOOOOO NOT GUNNA MISS IT. Get your tickets early Tomorrow by slapping that ask! SPOM SPoM SPoM
SCOOPING all SPOM low flying rockets!
SPOT ON SPOM REPLY!
SPOM Acquisition of Gerpang! Woooo
The acquisition is scheduled to close no later than February 18, 2020. At the time of closing, all officers and directors of SPO Global will resign and will be replaced by the management of Gerpang. The Company will acquire 100% of the assets of Gerpang, and Gerpang shareholders will acquire common shares equal to 80% of the fully diluted shares of common stock of the Company post-merger. At the time of merger, the Company will have no more than $42,000 of accounts payable and $ 12,500 of convertible debt.
DEVM Vantage Move in dates are April 15th: Sample units and Floor plans are on their Website
https://vantagestpete.com/floorplans/
SPOM is the Ticker here. XU not involved with ADSV that is MM and OCM SCAM.
SPOM Deal closes Tuesday!
The acquisition is scheduled to close no later than February 18, 2020. At the time of closing, all officers and directors of SPO Global will resign and will be replaced by the management of Gerpang. The Company will acquire 100% of the assets of Gerpang, and Gerpang shareholders will acquire common shares equal to 80% of the fully diluted shares of common stock of the Company post-merger. At the time of merger, the Company will have no more than $42,000 of accounts payable and $ 12,500 of convertible debt.
SPOM deal closes Tuesday! Market closed Monday! Get your Tickets today cause you can't Monday!
SPOM deal closes Tuesday! Market closed Monday! Get your Tickets today cause you can't Monday!
MYFT Seller gunna cry when they get news what is coming here.
MYFT Monday .003 and higher
Great Article on ENRT Lithium Brine Extraction method
http://wealthnewswire.com/lithium-stocks-signaling-bull-rush-in-2020-with-advancing-mid-cap-brine-water-lithium-providers/
MYFT being Gobbled up for some reason Reverse Merger or Take Over my Guess.